Your session is about to expire
← Back to Search
Brief Mindfulness Based Intervention for Suicidal Thoughts (MB-SI Trial)
N/A
Waitlist Available
Led By William R Marchand, MD, LFAPA
Research Sponsored by VA Salt Lake City Health Care System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Admitted with suicidal ideation and any active psychiatric or addictive disorder diagnosis.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-intervention, immediately post-intervention, and one month post-intervention
Awards & highlights
MB-SI Trial Summary
This trial will study whether a mindfulness intervention can help reduce suicidal ideation and related behaviors, as well as improve other measures, compared to usual treatment.
Eligible Conditions
- Suicidal Thoughts
- Mental Illness
- Addiction
MB-SI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMB-SI Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre-intervention and one month post-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-intervention and one month post-intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Measure P1: Change in Columbia Suicide Severity Rating Scale among the MB-SI + TAU cohort compared to the TAU only cohort
Secondary outcome measures
Measure S1: Number or category of patient and intervention characteristics
Measure S2: Change in psychiatric hospitalizations, emergency room visits for psychiatric illness, and emergency room visits
Measure S3: Change in TMS among the MB-SI + TAU cohort compared to the TAU only cohort
+2 moreMB-SI Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Brief Mindfulness Based InterventionExperimental Treatment1 Intervention
Some participants, as a result of random selection, will be asked to participate in four, 45-minute sessions that will occur on four separate days while on the Inpatient Psychiatric Unit (IPU). These four sessions are in addition to the standard IPU treatment and are experimental. These four sessions will include mindfulness meditation practice and education, creating a Crisis Response Plan, and a brief introduction into self-compassion. As stated above, practicing mindfulness means focusing attention on what is occurring in the present moment in a non-judgmental way. The focus may be on what one is seeing or hearing or physical sensations, such as touch, as well as thoughts and emotions. Meditation is just sitting quietly and practicing mindful awareness.
Group II: Treatment as UsualActive Control1 Intervention
Participants will be asked to fill out several short paper and pencil tests to assess your response to the treatment (10 to 15 minutes) pre-intervention and immediately post-intervention while on the Inpatient Psychiatric Unit (IPU), as well as a follow-up phone call or mail one month after discharge from the IPU. All participants will receive the IPU's normal standard of care treatment (for study purposes this called treatment as usual).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Brief Mindfulness Based Intervention
2019
N/A
~30
Find a Location
Who is running the clinical trial?
VA Salt Lake City Health Care SystemLead Sponsor
24 Previous Clinical Trials
264,906 Total Patients Enrolled
William R Marchand, MD, LFAPAPrincipal InvestigatorSalt Lake City Veterans' Administration Medical Center
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger